Coloplast A/S - Interim Financial Report, Q1 2023/24
Q1 2023/24Interim financial results, Q1 2023/241 October 2023 - 31 December 2023 Coloplast delivered a solid Q1 with 8% organic growth and an EBIT margin1) of 28%. Reported...
Stay updated with breaking news from Micro Hole Zone Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Q1 2023/24Interim financial results, Q1 2023/241 October 2023 - 31 December 2023 Coloplast delivered a solid Q1 with 8% organic growth and an EBIT margin1) of 28%. Reported...
Q1 2023/24Interim financial results, Q1 2023/241 October 2023 - 31 December 2023 Coloplast delivered a solid Q1 with 8% organic growth and an EBIT...
The new intermittent catheter Luja™ addresses important risk factors for urinary tract infections, a significant burden for people using intermittent...
03.02.2023 - Q1 2022/23 Interim financial results, Q1 2022/23 1 October 2022 – 31 December 2022 Coloplast delivered a solid start to the year with 7% organic growth and a 29% EBIT margin before special items Coloplast delivered 7% organic ... Seite 1
03.02.2023 - The new intermittent catheter Luja addresses important risk factors for urinary tract infections, a significant burden for people using intermittent catheters as well as healthcare systems as a whole. Urinary tract infections represent a ...